Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.70 is 54% below its 5-year average of 1.53, near the low end of its 5-year range (0.56–3.24).
As of the fiscal period ended Tuesday, June 30, 2026. 45.04% below its 12-month average of 1.27.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.70.
CURRENT RATIO
0.70
CURRENT RATIO AVG TTM
1.27
CURRENT RATIO AVG 3Y
1.82
CURRENT RATIO AVG 5Y
1.53
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-45.04%
CURRENT VS 3Y AVG
-61.55%
CURRENT VS 5Y AVG
-54.37%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.52
median of 723 covered companies
CURRENT VS SECTOR MEDIAN
-80.12%
vs the sector median at left
Ensysce Biosciences, Inc.
Market Cap
$6.43M
Current Ratio
0.70
TTM Avg
1.27
3Y Avg
1.82
5Y Avg
1.53
Market Cap
$6.50M
Current Ratio
10.21
TTM Avg
3.61
3Y Avg
3.34
5Y Avg
4.20
Market Cap
$6.07M
Current Ratio
17.15
TTM Avg
11.86
3Y Avg
7.50
5Y Avg
9.06
Market Cap
$6.91M
Current Ratio
0.31
TTM Avg
1.26
3Y Avg
1.91
5Y Avg
5.47
Market Cap
$5.91M
Current Ratio
119.39
TTM Avg
100.04
3Y Avg
53.39
5Y Avg
40.10
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ensysce Biosciences, Inc. (ENSC) | $6.43M | 0.70 | 1.27 | 1.82 | 1.53 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.50M | 10.21 | 3.61 | 3.34 | 4.20 |
| Femasys Inc. (FEMY)vs › | $6.31M | 2.14 | 2.73 | 5.58 | 6.46 |
| Biomerica, Inc. (BMRA)vs › | $6.32M | 1.62 | 2.21 | 3.63 | 4.38 |
| Aclarion, Inc. (ACON)vs › | $6.66M | 16.20 | 7.76 | 4.60 | 3.08 |
| Co-Diagnostics, Inc. (CODX)vs › | $6.75M | 1.81 | 4.14 | 10.76 | 11.50 |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.07M | 17.15 | 11.86 | 7.50 | 9.06 |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $6.91M | 0.31 | 1.26 | 1.91 | 5.47 |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.91M | 119.39 | 100.04 | 53.39 | 40.10 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.99M | 2.61 | 3.40 | 4.86 | 5.09 |
Current Ratio
0.70
Quick Ratio
N/A
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.70 |
| 2026-03-31 | 0.71 |
| 2025-12-31 | 1.59 |
| 2025-09-30 | 1.27 |
| 2025-06-30 | 2.10 |
| 2025-03-31 | 2.50 |
| 2024-12-31 | 2.42 |
| 2024-09-30 | 3.24 |
| 2024-06-30 | 1.88 |
| 2024-03-31 | 2.87 |
| 2023-12-31 | 0.69 |
| 2023-09-30 | 1.36 |
| 2023-06-30 | 2.33 |
| 2023-03-31 | 0.85 |
| 2022-12-31 | 0.56 |
| 2022-09-30 | 0.64 |
| 2022-06-30 | 0.87 |
| 2022-03-31 | 1.32 |
| 2021-12-31 | 0.95 |
| 2021-09-30 | 1.27 |
| 2021-06-30 | 2.07 |
| 2021-03-31 | 0.14 |
| 2020-12-31 | 0.05 |
| 2020-09-30 | 0.23 |
| 2020-06-30 | 0.23 |
| 2020-03-31 | 0.08 |
| 2019-12-31 | 0.43 |
| 2019-09-30 | 1.22 |
| 2019-06-30 | 4.49 |
| 2019-03-31 | 4.16 |
| 2018-12-31 | 4.38 |
| 2018-09-30 | 5.24 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 10.77 |
| 2017-12-31 | 0.00 |
| 2017-09-30 | 0.89 |
